508 related articles for article (PubMed ID: 8876155)
1. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
[TBL] [Abstract][Full Text] [Related]
2. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
[TBL] [Abstract][Full Text] [Related]
3. Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits.
Hoeg JM; Vaisman BL; Demosky SJ; Meyn SM; Talley GD; Hoyt RF; Feldman S; Bérard AM; Sakai N; Wood D; Brousseau ME; Marcovina S; Brewer HB; Santamarina-Fojo S
J Biol Chem; 1996 Feb; 271(8):4396-402. PubMed ID: 8626790
[TBL] [Abstract][Full Text] [Related]
4. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis.
Mehlum A; Gjernes E; Solberg LA; Hagve TA; Prydz H
APMIS; 2000 May; 108(5):336-42. PubMed ID: 10937770
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
[TBL] [Abstract][Full Text] [Related]
7. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
[TBL] [Abstract][Full Text] [Related]
8. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase.
Bérard AM; Föger B; Remaley A; Shamburek R; Vaisman BL; Talley G; Paigen B; Hoyt RF; Marcovina S; Brewer HB; Santamarina-Fojo S
Nat Med; 1997 Jul; 3(7):744-9. PubMed ID: 9212100
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner.
Brousseau ME; Santamarina-Fojo S; Vaisman BL; Applebaum-Bowden D; Bérard AM; Talley GD; Brewer HB; Hoeg JM
J Lipid Res; 1997 Dec; 38(12):2537-47. PubMed ID: 9458277
[TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
Furbee JW; Parks JS
Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
[TBL] [Abstract][Full Text] [Related]
11. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.
Santamarina-Fojo S; Lambert G; Hoeg JM; Brewer HB
Curr Opin Lipidol; 2000 Jun; 11(3):267-75. PubMed ID: 10882342
[TBL] [Abstract][Full Text] [Related]
12. Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.
Brousseau ME; Santamarina-Fojo S; Zech LA; Bérard AM; Vaisman BL; Meyn SM; Powell D; Brewer HB; Hoeg JM
J Clin Invest; 1996 Apr; 97(8):1844-51. PubMed ID: 8621767
[TBL] [Abstract][Full Text] [Related]
13. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
14. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
Furbee JW; Sawyer JK; Parks JS
J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
[TBL] [Abstract][Full Text] [Related]
16. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
[TBL] [Abstract][Full Text] [Related]
17. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.
Séguret-Macé S; Latta-Mahieu M; Castro G; Luc G; Fruchart JC; Rubin E; Denèfle P; Duverger N
Circulation; 1996 Nov; 94(9):2177-84. PubMed ID: 8901669
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
Van Craeyveld E; Lievens J; Jacobs F; Feng Y; Snoeys J; De Geest B
Gene Ther; 2009 Jun; 16(6):757-65. PubMed ID: 19242527
[TBL] [Abstract][Full Text] [Related]
19. [Reverse cholesterol transport and use of transgenic mice and rabbits to reveal candidate genes for protection against atherosclerosis].
Fruchart JC; Duriez P
Bull Acad Natl Med; 1998; 182(2):233-47; discussion 247-9. PubMed ID: 9648340
[TBL] [Abstract][Full Text] [Related]
20. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
